Nigeria imports over 70% of its finished pharmaceutical products, and India is by far the largest source of those imports. For any Indian manufacturer serious about Africa, Nigeria is not optional — it is the anchor market. Population growth, urbanisation, and a chronically under-supplied public health system have combined to create structural demand that will not soften for at least a decade.
The opportunity is layered rather than uniform. High-volume anti-infectives, analgesics, anti-malarials and anti-diabetics dominate retail pharmacy shelves and are almost entirely served by imported Indian generics. Institutional tenders — through the Federal Ministry of Health, state governments and donor-funded procurement — provide predictable off-take at lower margin but very high volume. Layered on top is a fast-growing OTC and wellness segment where Indian brands can build genuine consumer equity, not just supply commoditised molecules.
The regulatory path is well-understood. NAFDAC registration takes 9–14 months on average, and requires a Nigerian legal representative — typically your distributor. The key mistake exporters make is treating NAFDAC as a paperwork exercise instead of a strategic gating decision: which 8–12 dossiers you choose to register will define your revenue mix for the next five years. Pick fast-movers with clear price-to-shelf economics, not your entire portfolio.
Distribution is where most Indian entrants stumble. Nigeria has a handful of genuinely national distributors and dozens of regional players who claim to be national. The right structure is usually one strong lead distributor with formal sub-distributor networks in the South-West (Lagos-Ibadan), South-East (Onitsha-Aba), North (Kano-Kaduna) and Abuja. Exclusivity should be earned quarter-by-quarter against volume commitments, never handed out on day one.
The winning three-year playbook is: Year 1 — register 8–12 fast-moving dossiers, appoint a national distributor with regional sub-networks, and invest in medical representative training. Year 2 — layer in OTC brand building, expand the SKU count to 20+, and pilot institutional tender participation. Year 3 — establish local co-packing or secondary packaging to unlock the price advantage of the Nigerian Content Development framework, and begin re-export into Ghana, Cameroon and Niger.
Payment risk is real but manageable. Advance payment or confirmed letters of credit are standard for the first 12 months; graduate a distributor to 30-day credit only after two years of clean payment history. Foreign exchange volatility around the naira is a bigger day-to-day issue than credit risk — price contracts in USD, review quarterly, and build in an FX escalation clause.
Nigeria rewards manufacturers who show up in person. A single week of distributor meetings in Lagos does more than six months of email exchanges. Budget for two founder-led visits per year in the first three years — it is the single highest-ROI investment you will make in the market.